SEC filings
Zoetis (ZTS)
Recent filings Zoetis made with the SEC, newest first. Most have a short AI-generated summary, and every one links to the original.
CIK 0001555280All filings on SEC.gov
10-QQuarterly report
Quarterly report
Zoetis reported third-quarter 2026 revenue of $2.39 billion, down 1% from a year earlier, and net income attributable to Zoetis of $591 million, down 18%, while nine-month revenue was roughly flat at $7.12 billion and nine-month net income…
8-KCurrent report
Results of Operations and Financial Condition
Zoetis reported third-quarter 2026 revenue of $2.4 billion, down 1% from a year earlier, with net income of $591 million (down 18%) and adjusted diluted EPS of $1.75 (up 3%), and narrowed its full-year 2026 revenue guidance to $9.22–$9.32…
8-KCurrent report
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Regulation FD Disclosure
Zoetis Inc. appointed Iris Knobloch to its board of directors effective December 1, 2026, increasing the board from twelve to thirteen members, and she will serve on its Corporate Governance Committee. …
8-KCurrent report
Regulation FD Disclosure
Zoetis Inc.'s board of directors declared a fourth-quarter 2026 dividend of $0.53 per share, payable December 1, 2026, to holders of record as of the close of business on October 30, 2026.
8-KCurrent report
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Zoetis appointed James (Jay) Saccaro as Executive Vice President, Chief Financial Officer and Chief Operating Officer effective August 17, 2026, with Saccaro joining from GE HealthCare where he was CFO; …
10-QQuarterly report
Quarterly report
Zoetis reported second-quarter 2026 revenue of $2.47 billion, essentially flat versus the prior-year period, with net income attributable to Zoetis down 5% to $691 million and adjusted net income down 1% to $781 million. …
8-KCurrent report
Results of Operations and Financial Condition
Zoetis reported flat second-quarter 2026 revenue of $2.5 billion and net income of $691 million, or $1.65 per diluted share, and revised its full-year 2026 guidance down to $9.120–$9.320 billion in revenue and $6.15–$6.25 in adjusted…
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.
Follow Zoetis in Readster
Add Zoetis to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.
No credit card. When the trial ends, you move to Readster Free unless you subscribe.